Obstetrics

Approved for use at 32 weeks through 36 weeks gestation, Pfizer’s maternal respiratory syncytial vaccine (Abrysvo), is delivered through a single dose injection to the muscle, and is the first vaccine for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD because of RSV in infants (birth to 6 months).

In a recent study, patients at risk of perinatal mood and anxiety disorders presented with different plasma protein levels than those not at risk.

The Maternal Health Research Centers of Excellence will work to reduce maternal mortality in the United States, with a focus on populations which face disparities in health care.

In a recent study, hospitalization rates were reduced among women enrolled in a postpartum navigation program.

The spiral tampon provides a more comfortable option with improved absorption capabilities.

In a recent study, temporal trends indicated a rise in induction at 39 weeks of gestation and decrease in cesarean delivery among low-risk nulliparous patients in the United States.

In a recent study, only blood pressure levels considered stage 2 hypertension were useful for predicting adverse pregnancy outcomes.

In a recent study, improved knowledge on preterm birth risks were seen in patients receiving a smartphone-based preterm birth education program.

The first oral treatment for postpartum depression works in as little as 3 days and provides hope for women who suffer from this debilitating mental condition.

As the United States experiences an opioid crisis, how are pregnant individuals impacted?

The past few years have seen significant changes to the health care landscape, but how can physicians in obstetrics and gynecology adapt?

In a recent study, rates of unhoused status in pregnant patients increased over a 5-year period, with severe maternal morbidity and other adverse events more common in unhoused pregnant patients.

In a recent study, preterm preeclampsia was seen more often in women with specific metabolite biomarkers.

A study from Denmark leveraging more than 40 million years of follow-up data from patients dating back to the 1950s offers insight into the apparent increase in the risk of myocardial infarction associated with pregnancy loss in women and whether this same effect is observed in male partners.

Researchers have developed a method of administrating methotrexate through polymersomes for improved efficacy when treating ectopic pregnancy.

In a recent study, patients receiving hybrid fetoscopic repair experienced fewer obstetrical complications than those received open repair.

In a recent study, women with adenomyosis were at greater risks of adverse obstetrical and neonatal events.

More evidence is needed to help clinicians manage chronic hypertension.

As awareness spreads on the adverse impact caused by postpartum hemorrhage, investigators are working to streamline management.

Updates in management

In a recent study, increased rates of severe maternal morbidity were observed among hospitals with a lower obstetric volume in rural settings, but not urban settings.

The American Indian and Alaska Native population show the largest increase in median state ratios, rising from 14 - 49.2, while the Black population consistently had the highest median state ratios, increasing from 26.7 - 55.4.

Hugh Taylor, MD, discusses topic which will be presented at the 4th Annual International Congress on the Future of Women’s Health.

In a recent review, the associations between components of lifestyle interventions and reductions in gestational weight gain were unclear.

In a recent study, rates of maternal morbidity increased in 2021 compared to 2008, while in-hospital mortality rates were reduced.

In a recent study, positive safety and efficacy were found in patients taking mifepristone against adenomyosis.

In a recent study, pregnant individuals residing in neighborhoods with greater densities of unhealthy food were at an increased risk of giving birth to infants who were small for gestational age or large for gestational age.

Emre Seli, MD, chief scientific officer of the March of Dimes, discusses the organization's initiative to research recurrent pregnancy loss.

Technology may be used in ultrasounds, fetal heart rate interpretation, and prediction of adverse clinical outcomes.

In this video interview, experts provide a synopsis of their presentation about technology and obstetric care at the 2023 ACOG Annual Clinical and Scientific Meeting.